CDPHP® is committed to providing you with timely, useful, and actionable information and resources on topics related to health, wellness, and our corporate activities. In this section, you can find news, perspectives and commentary, and updates on industry challenges that may affect our company, our constituents, and the communities we serve.
To continue to stay current on company happenings, be sure to check out our comprehensive Newsroom.
We appreciate your interest in CDPHP and welcome your comments.
CDPHP® works hard to ensure our administrative costs are not our members’ burden, and that we spend a vast majority of your premium dollars on medical care. For the fourth year in a row, CDPHP has spent more than federal and state requirements on our members’ medical care and exceeded the standards for medical loss ratio. continue reading →
The U.S. Supreme Court ruled on King v. Burwell, upholding a key provision of the Affordable Care Act (ACA) that grants subsidies to individuals who purchase health care coverage on the federal marketplace. continue reading →
Have you ever lived in a neighborhood where it’s obvious that two people are competing over the nicest lawn or newest car? It’s fun to watch, right? You know these guys are doling out oodles of cash just to one-up each other. What’s not fun to watch is when this sort of thing happens in health care. continue reading →
When the price of a product is low, no one seems to care. But when product prices rise, everyone wants to know why. Suddenly, Congress is holding hearings, analysts are weighing in on major news networks, and the American public is paying attention. Rightfully so, you deserve to know where your hard-earned money is being spent. continue reading →
For years, health plans – like CDPHP – have encouraged members to request generic drugs as a way to save money. Generics, which are chemically identical to their brand-name counterparts, are created after a drug patent expires. They can often be sold at a fraction of the price because the manufacturer doesn’t assume the cost of developing the drug. However, the recent rise in the cost of many generic medications is causing major concern among health industry experts as doctors, patients, and health plans run out of alternatives for pricey prescriptions.